Canada - fransk - Health Canada

apotex inc - travoprost - solution - 0.004% - travoprost 0.004% - prostaglandin analogs

Canada - fransk - Health Canada

pharmascience inc - travoprost - solution - 0.004% - travoprost 0.004% - prostaglandin analogs

Canada - fransk - Health Canada

mylan pharmaceuticals ulc - travoprost - solution - 0.004% - travoprost 0.004% - prostaglandin analogs

Canada - fransk - Health Canada

novartis pharmaceuticals canada inc - travoprost - solution - 0.004% - travoprost 0.004% - prostaglandin analogs

Den Europæiske Union - fransk - EMA (European Medicines Agency)

seqirus s.r.l.  - antigènes de surface du virus de la grippe, inactivés: a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccins contre la grippe - prophylaxie de la grippe dans une situation de pandémie officiellement déclarée. le vaccin contre la grippe pandémique doit être utilisé conformément aux directives officielles.

Schweiz - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - filgrastimum - solution injectable - filgrastimum 30 mio. u., acidum aceticum glaciale, natrii hydroxidi solutio 18% m/m corresp. natrium 31.9 µg, polysorbatum 80, sorbitolum 50 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - la neutropénie - biotechnologika

Schweiz - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - filgrastimum adnr - solution injectable - filgrastimum adnr 48 mio. u., natrii acetas trihydricus, sorbitolum, polysorbatum 80, aqua ad iniectabilia q.s. ad solutionem pro 1.6 ml. - neutropenie - biotechnologika

Schweiz - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - filgrastimum - solution injectable dans une seringue préremplie - filgrastimum 30 mio. u., acidum aceticum glaciale, natrii hydroxidi solutio 18% m/m corresp. natrium 15.9 µg, polysorbatum 80, sorbitolum 25 mg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - la neutropénie - biotechnologika

Schweiz - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - filgrastimum - solution injectable dans une seringue préremplie - filgrastimum 48 mio. u., acidum aceticum glaciale, natrii hydroxidi solutio 18% m/m corresp. natrium 15.9 µg, polysorbatum 80, sorbitolum 25 mg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - la neutropénie - biotechnologika

Den Europæiske Union - fransk - EMA (European Medicines Agency)

vbi vaccines b.v. - antigène de surface de l'hépatite b - hépatite b - vaccins - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.